Non-Billable / Non-Specific Code
ICD-10-CM C7B is the diagnosis code for Secondary neuroendocrine tumors. This code falls under the section "Secondary neuroendocrine tumors" within Chapter 2 — Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where C7B sits in the ICD-10-CM classification helps ensure proper coding:
No, C7B is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C7B is the ICD-10-CM diagnosis code for "Secondary neuroendocrine tumors". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C7B is located in Section C7B — "Secondary neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
C7B has 3 sub-code(s) that provide more specific detail: C7B.0, C7B.1, C7B.8.
Use C7B when the patients documented diagnosis matches "Secondary neuroendocrine tumors" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Secondary neuroendocrine tumors is C7B.
No, C7B is non-billable. Use a more specific sub-code for primary diagnosis billing.
C7B is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C7B is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.